Suven Pharmaceuticals
BSE: 543064 | NSE: SUVENPHAR | ISIN: INE03QK01018 | SECTOR: Biotechnology & DrugsRatios
- Management Effectiveness
- Margins
- Financial Strength
- Valuation
- Income Statement
- Growth
- Per Share Data
- Price and Volume
Return on average equity - 5 year average
-Net Income/employee - trailing 12 month
31,83,509.00Revenue/employee - most recent fiscal year
1,13,68,350.00Return on investment - most recent fiscal year
24.01Return on average assets - most recent fiscal year
21.67Receivables turnover - most recent fiscal year
7.71Return on investment - trailing 12 month
-Return on average assets - trailing 12 month
-Inventory turnover - most recent fiscal year
1.80Inventory turnover - trailing 12 month
-Revenue/employee - trailing 12 month
1,00,23,860.00Return on average assets - 5 year average
-Net Income/employee - most recent fiscal year
34,88,467.00Return on average equity - trailing 12 month
-Receivables turnover - trailing 12 month
-Asset turnover - most recent fiscal year
0.71Asset turnover - trailing 12 month
-Return on average equity - most recent fiscal year
25.21Return on investment - 5 year average
-